Literature DB >> 22045674

Human hepatocellular carcinomas with "Stemness"-related marker expression: keratin 19 expression and a poor prognosis.

Haeryoung Kim1, Gi Hong Choi, Deuk Chae Na, Ei Young Ahn, Gwang Il Kim, Jae Eun Lee, Jai Young Cho, Jeong Eun Yoo, Jin Sub Choi, Young Nyun Park.   

Abstract

UNLABELLED: There is a recently proposed subtype of hepatocellular carcinoma (HCC) that is histologically similar to usual HCC, but characterized by the expression of "stemness"-related markers. A large-scale study on two different cohorts of HCCs was performed to investigate the clinicopathologic features and epithelial-mesenchymal transition (EMT)-related protein expression status of this subtype of HCCs. The expression status of stemness-related (e.g., keratin 19 [K19], cluster of differentiation [CD]133, epithelial cell adhesion molecule [EpCAM], and c-kit) and EMT-related markers (e.g., snail, S100A4, urokinase plasminogen activator receptor [uPAR], ezrin, vimentin, E-cadherin, and matrix metalloproteinase [MMP]2) were examined using tissue microarrays from cohort 1 HCCs (n = 137). K19 protein expression in cohort 2 HCCs (n = 237) was correlated with the clinicopathologic parameters and messenger RNA (mRNA) levels of K19, uPAR, VIL2, Snail, Slug, and Twist. K19, EpCAM, c-kit, and CD133 positivity were observed in 18.2%, 35.0%, 34.3%, and 24.8%, respectively. K19 was most frequently expressed in combination with at least one other stemness-related marker (92.0%). K19-positive HCCs demonstrated more frequent major vessel invasion and increased tumor size, compared to K19-negative HCCs (P < 0.05). K19 was most significantly associated with EMT-related protein expression (e.g., vimentin, S100A4, uPAR, and ezrin) (P < 0.05) and a poor prognosis (overall survival: P = 0.018; disease-free survival: P = 0.007) in cohort 1. In cohort 2, HCCs with high K19 mRNA levels demonstrated higher mRNA levels of Snail, uPAR, and MMP2 (P < 0.05). K19-positive HCCs demonstrated more frequent microvascular invasion, fibrous stroma, and less tumor-capsule formation, compared to K19-negative HCCs (P < 0.05). K19 expression was a significant independent predictive factor of poor disease-free survival (P = 0.032).
CONCLUSION: K19 was well correlated with clinicopathologic features of tumor aggressiveness, compared to other stemness-related proteins. K19-positive HCCs showed significantly increased EMT-related protein and mRNA expression, suggesting that they may acquire more invasive characteristics, compared to K19-negative HCCs through the up-regulation of EMT-associated genes.
Copyright © 2011 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22045674     DOI: 10.1002/hep.24559

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  130 in total

Review 1.  Evaluation of antiangiogenic efficacy in advanced hepatocellular carcinoma: Biomarkers and functional imaging.

Authors:  Mohamed Bouattour; Audrey Payancé; Johanna Wassermann
Journal:  World J Hepatol       Date:  2015-09-18

2.  Perinodular ductular reaction/epithelial cell adhesion molecule loss in small hepatic nodules.

Authors:  Qin Zhang; Chuan-Shan Zhang; Qi Xin; Zhe Ma; Gui-Qiu Liu; Bing-Bing Liu; Feng-Mei Wang; Ying-Tang Gao; Zhi Du
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

3.  Analysis of Lipiodol uptake in angiography and computed tomography for the diagnosis of malignant versus benign hepatocellular nodules in cirrhotic liver.

Authors:  Marcel C Langenbach; Thomas J Vogl; Isabelle von den Driesch; Benjamin Kaltenbach; Jan-Erik Scholtz; Renate M Hammerstingl; Tatjana Gruber-Rouh
Journal:  Eur Radiol       Date:  2019-06-24       Impact factor: 5.315

Review 4.  Liver cancer stem cell markers: Progression and therapeutic implications.

Authors:  Jing-Hui Sun; Qing Luo; Ling-Ling Liu; Guan-Bin Song
Journal:  World J Gastroenterol       Date:  2016-04-07       Impact factor: 5.742

Review 5.  Tissue diagnosis of hepatocellular carcinoma.

Authors:  Deepali Jain
Journal:  J Clin Exp Hepatol       Date:  2014-04-01

Review 6.  Biphenotypic (hepatobiliary) primary liver carcinomas: the work in progress.

Authors:  Elizabeth M Brunt; Valerie Paradis; Christine Sempoux; Neil D Theise
Journal:  Hepat Oncol       Date:  2015-07-28

7.  HMGB1 links chronic liver injury to progenitor responses and hepatocarcinogenesis.

Authors:  Celine Hernandez; Peter Huebener; Jean-Philippe Pradere; Daniel J Antoine; Richard A Friedman; Robert F Schwabe
Journal:  J Clin Invest       Date:  2018-05-07       Impact factor: 14.808

8.  Epithelial-mesenchymal transition expression profiles as a prognostic factor for disease-free survival in hepatocellular carcinoma: Clinical significance of transforming growth factor-β signaling.

Authors:  Kosuke Mima; Hiromitsu Hayashi; Hideyuki Kuroki; Shigeki Nakagawa; Hirohisa Okabe; Akira Chikamoto; Masayuki Watanabe; Toru Beppu; Hideo Baba
Journal:  Oncol Lett       Date:  2012-10-05       Impact factor: 2.967

9.  Expression of K19 and K7 in dysplastic nodules and hepatocellular carcinoma.

Authors:  Jun Sang Bae; Ha Na Choi; Sang Jae Noh; Byung Hyun Park; Kyu Yun Jang; Cheol Keun Park; Woo Sung Moon
Journal:  Oncol Lett       Date:  2012-05-25       Impact factor: 2.967

10.  Immunohistochemistry panel segregates molecular types of hepatocellular carcinoma in Brazilian autopsy cases.

Authors:  Aloísio Felipe-Silva; Alda Wakamatsu; Cinthya Dos Santos Cirqueira; Venâncio Avancini Ferreira Alves
Journal:  World J Gastroenterol       Date:  2016-07-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.